RegenPRP — autologous PRP prepared chairside in a closed circuit, for scalp biostimulation in pattern hair loss. Single session. CE-marked.
Request clinical documentation or distributor information for your region.
RegenPRP is RegenLab’s autologous platelet-rich plasma, applied here to the scalp. Prepared chairside in a closed circuit and delivered in a single session, it offers clinicians a biostimulation approach to thinning hair that works from the patient’s own blood.
Pattern hair loss is one of the most common reasons patients present to dermatology and aesthetic clinics, and for many it begins well before they are ready to consider surgery. The established options each carry trade-offs. Daily topical minoxidil and oral agents can slow progression, but they demand indefinite adherence, and not every patient tolerates them or wants a lifelong prescription. Surgical restoration addresses advanced, stable loss, yet it is an operation — with cost, recovery and a severity threshold most early patients have not reached. That leaves a large group in between: people with visible thinning who are motivated to act but are neither well served by topicals alone nor candidates for a transplant. Autologous scalp biostimulation is aimed at this earlier window, using components from the patient’s own blood to support the follicular environment within a single in-office procedure.
The rationale for treating the scalp with autologous PRP rests on how much the follicle depends on its surrounding environment. RegenPRP concentrates the patient’s own platelets, which release growth factors — PDGF, TGF-β, VEGF, EGF and others — that take part in the signalling around the dermal papilla and the perifollicular tissue when introduced into the scalp. The aim is to support the local environment in which the follicle cycles, rather than to add any external active. What makes the preparation dependable is standardisation: RegenPRP is leucocyte-reduced and produced in a closed circuit with a fixed separating-gel technology, so the platelet concentrate is reproducible from one session and one practitioner to the next. Delivered by intradermal injection across the affected areas of the scalp, it is a single autologous product, prepared and administered in one appointment.
The whole preparation is carried out in the room with the patient, start to finish. A small blood sample is taken directly into the single-use RegenPRP device; one centrifugation then separates the platelet-rich plasma from the red cells through the fixed separating gel, with no pouring, pipetting or hand-mixing at any point. The prepared autologous PRP is delivered by fine intradermal injection across the affected areas of the scalp in the same visit. Running everything through a closed, disposable circuit is intentional: it strips out the open steps where contamination and inconsistency creep in, and it keeps the procedure within the scope of a routine consultation — no separate laboratory, no cell-processing hardware, no return appointment for the patient. The injection pattern, depth and session cadence specific to the scalp are documented on the product page.
With platelet therapies, the value of any published result hinges on how consistent the underlying preparation is; when the product drifts between sessions, outcomes become hard to compare. Standardising the platelet concentrate inside a closed system removes that variable, so each scalp treatment begins from the same starting point regardless of who performs it — RegenPRP is leucocyte-reduced and reproducible by design. RegenLab’s technologies rest on a broad base of independent, peer-reviewed research, including work in androgenetic alopecia and other hair-related applications that clinicians can consult when judging whether the approach fits their patients. Rather than paraphrase individual studies here, our science hub assembles the relevant references together, so they can be read in full and checked against what each market permits to be claimed. Practitioners weighing RegenPRP for the scalp should go through both that literature and the regulatory documentation in force in their region first.
For hair, RegenLab uses plain autologous PRP — hyaluronic acid is not added. The PRP-HA (Cellular Matrix) combination is reserved for other indications such as knee osteoarthritis and skin.
Pattern (androgenetic) thinning, typically at an earlier stage before surgical candidacy.
Yes — the sample is drawn, prepared and applied to the scalp in the same visit, with no external lab step.
Yes, under the EU Medical Device Regulation (MDR).
Through the contact form; our team connects you with the distributor for your region.